CMS Open Payments · Program Year 2024
Bausch Health US, LLC
Bausch Health US, LLC reported $22,456,290.23 across General Payments, Research, and Ownership to 9,197 physicians and teaching hospitals across 19,274 transactions.
- $22.5M Top 10% payer
- All-tracks total
- 19,274 Top 10% volume
- Transactions
- 9,197 Top quartile reach
- Recipients
- +$77.5K
- General Payments vs PY2023
Bausch Health US, LLC reported $22,456,290.23 across all CMS Open Payments tracks (General + Research + Ownership) to 9,197 physicians and teaching hospitals in Program Year 2024 - ranking #85 of 1,925 reporting manufacturers (0.2% of the all-tracks industry total); General Payments alone were $639,950.85, averaging $2.4K per recipient.
How Bausch Health US, LLC's $22.5M all-tracks total breaks down
Bausch Health US, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
89/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
B
80/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bausch-health-us-llc Bausch Health US, LLC
$22.5M · #85/1,925 · 0.2% industry · PY2024
- TOT $22.5M
- RANK #85
- SHARE 0.2%
- TXN 19,274
- RCP 9,197
- CAT 6
- GEN $640.0K
- ΔGEN +$77.5K
- TOP1 59.4%
- PY 2024
Volume peers
Nearest volume peer: Alphatec Spine, Inc ($22.3M)
Bausch Health US, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Bausch Health US, LLC's CMS-reported General Payments increased by $77.5K (+13.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BAUSCH HEALTH US, LLCPY2023: BAUSCH HEALTH US, LLCPY2024: Bausch Health US, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $562,428.29
- PY2024
- $639,950.85
What the Data Shows for Bausch Health US, LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Bausch Health US, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
5 transactions worth $277.5K make "Honoraria" the top general-payment category in the 6-category breakdown below, 43.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 6 types of general payments, Bausch Health US, LLC's largest category was "Honoraria" at $277.5K - 43.4% of General Payments.
Bausch Health US, LLC reports 6 general-payment categories - the top three are Honoraria (43.4%), Food and Beverage (26.1%), and Compensation for Services Other Than Consulting (15.6%). The remaining 3 categories make up 14.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Bausch Health US, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $277.5K | 5 | 43.4% |
| Food and Beverage | $167.0K | 8,917 | 26.1% |
| Compensation for Services Other Than Consulting | $100.0K | 4 | 15.6% |
| Consulting Fee | $92.9K | 24 | 14.5% |
| Travel and Lodging | $2.3K | 6 | 0.4% |
| Education | $253.05 | 241 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $452,621.26 (70.7%) of $639,950.85 in this company's General Payments records across 3,249 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Bausch Health US, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Amy Wechsler
$380,208.11 across 25 reported transactions
- 2
Joseph Pergolizzi
$40,460.00 across 2 reported transactions
- 3
Andrew Blumenfeld
$16,250.00 across 2 reported transactions
- 4
Peter Kowey
$10,800.00 across 2 reported transactions
- 5
Douglas Sears
$4,903.15 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Bausch Health US, LLC ranks #85 of 1,925 by total payments (top 4% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #491 of 1,838 by HHI (top 27% most concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Epizyme, Inc. : $16.4K total payments, HHI 3641
- OrphAI Therapeutics Inc. : $24.4K total payments, HHI 3624
- Flume Catheter Company Inc. : $15.0K total payments, HHI 3600
- Skeletal Dynamics Inc : $2.8M total payments, HHI 3598
- CooperSurgical, Inc. : $1.9M total payments, HHI 3590
- Medicines360 : $319.8K total payments, HHI 3588
- Bausch Health US, LLC (this company) : $640.0K total payments, HHI 3581
- Canon Medical Systems Corporation : $74.1K total payments, HHI 3576
- Acarix USA Inc. : $215.3K total payments, HHI 3569
- Natus Medical Incorporated : $59.5K total payments, HHI 3565
- Therakos Healthcare LLC : $35.7K total payments, HHI 3564
- CMF Medicon Surgical Inc. : $9.8K total payments, HHI 3560
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Bausch Health US, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Bausch Health US, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Bausch Health US, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Deciphera Pharmaceuticals Inc.
Aadi Bioscience, Inc.
Axsome Therapeutics, Inc.
Alcon Research LLC
Sage Therapeutics, Inc.
Put this to use
Bausch Health US, LLC ranks #85 of 1,925 by all-tracks total payments, led by "Honoraria".
- See where Bausch Health US, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Bausch Health US, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.